Anne Sophie Bajeot
Overview
Explore the profile of Anne Sophie Bajeot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roumiguie M, Seisen T, Masson-Lecomte A, Prost D, Allory Y, Xylinas E, et al.
Fr J Urol
. 2024 Nov;
34(12):102722.
PMID: 39581669
Introduction: The purpose of this study was to propose an update of the French guidelines from the national committee ccAFU on upper tract urothelial carcinomas (UTUC). Methods: A systematic Medline...
2.
Roumiguie M, Leon P, Xylinas E, Allory Y, Audenet F, Bajeot A, et al.
Fr J Urol
. 2024 Nov;
34(12):102742.
PMID: 39581667
Objective: To update the CCAFU recommendations for the management of non-muscle invasive bladder cancer (NMIBC). Methods: A systematic review (Medline) of the literature from 20222024 was performed, taking into account...
3.
Roumiguie M, Marcq G, Neuzillet Y, Bajeot A, Allory Y, Sargos P, et al.
Fr J Urol
. 2024 Nov;
34(12):102741.
PMID: 39581664
Objective: To update the CCAFU recommendations for the management of muscle-invasive bladder cancer (MIBC). Methods: A systematic review (Medline) of the literature from 2022 to 2024 was carried out, taking...
4.
Levy S, Pericart S, Bajeot A, Fakhfakh S, Lesourd M, Soulie M, et al.
World J Urol
. 2024 Aug;
42(1):475.
PMID: 39115589
Background: A second look trans-urethral resection of the bladder (re-TUR) is recommended after the diagnosis of T1 high grade (T1HG) bladder cancer. Few studies have evaluated the results of re-TUR...
5.
Courboin E, Mathieu R, Panetta V, Mjaess G, Diamand R, Verhoest G, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835425
Background: For non-muscle-invasive bladder cancer (NMIBC) requiring radical surgery, limited data are available comparing robotic-assisted radical cystectomy with intracorporeal urinary diversion (iRARC) to open radical cystectomy (ORC). The objective of...
6.
Marcq G, Afferi L, Neuzillet Y, Nykopp T, Voskuilen C, Furrer M, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497222
Introduction: Adjuvant therapy has no defined role for patients with positive surgical margins (PSMs) following radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC). The aim of our study was to...
7.
Mjaess G, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, et al.
Eur J Surg Oncol
. 2022 Aug;
49(8):1511-1518.
PMID: 35970622
Background: Robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) is surging worldwide. Aim of the study was to perform a multicentric cost-analysis of RARC by comparing the gross cost...
8.
Afferi L, Lonati C, Montorsi F, Briganti A, Necchi A, Mari A, et al.
Eur Urol Oncol
. 2022 Jun;
5(6):722-725.
PMID: 35715319
A trend towards greater benefit from adjuvant chemotherapy (ACT) in pN+ bladder cancer (BCa) has been observed in multiple randomized controlled trials. However, it is still unclear which patients might...
9.
Arora A, Zugail A, Pugliesi F, Cathelineau X, Macek P, Barbe Y, et al.
World J Urol
. 2022 Apr;
40(7):1697-1705.
PMID: 35488914
Objective: To determine whether use of neoadjuvant chemotherapy (NAC) is associated with a higher risk of post-operative complications following radical cystectomy (RC) for bladder cancer (BCa). Materials And Methods: We...
10.
Afferi L, Lonati C, Montorsi F, Briganti A, Necchi A, Mari A, et al.
World J Urol
. 2022 Feb;
40(6):1489-1496.
PMID: 35142865
Purpose: To test the impact of carboplatin-based ACT on overall survival (OS) in patients with pN1-3 cM0 BCa. Methods: A retrospective analysis was conducted on 1057 patients with pTany pN1-3...